Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial

By afschroeder • May 2, 2026

Martínez E, Watanabe M, Hoffman R, Zanni MV, Pozniak A, Shakil SS, McCallum S, Chu SM, Srinivasa S, Malvestutto CD, Fichtenbaum CJ, Bloomfield GS, Sponseller CA, Lu AB, Lu MT, Aberg JA, Currier JS, Douglas PS, Ribaudo HJ, Grinspoon SK; REPRIEVE Investigators. Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial. Lancet HIV. 2026 May;13(5):e327-e337. doi: 10.1016/S2352-3018(26)00036-6. PMID: 42067280.

Tags: Cardiology/Epi, Infectious Diseases, Publications

Orchestration of Endothelial and Osteogenic Marker Expression During Osteogenesis

Chen S, Zhao Y, Chen N, Wu X, Zhang L, Jing Z, Qi L, Cai X, Boström KI, Yao Y. Orchestration of Endothelial and Osteogenic[...]

Sex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological Malignancies

Keramida K, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Dent S, Drakaki A, Fuster JJ, Mamas MA, Okwuosa T, Scarfo L, Van Der Meer[...]

Regional heterogeneity and sex differences along the mouse aorta

Sveeggen TM, Kosmach A, Mitchell R, Brockmann BC, Meisinger TM, Stratman AN, Mack JJ, Cook JR, Bagher P. Regional heterogeneity and sex differences along the[...]